Rua Bioscience Limited — Share Issue/Capital Change 2024

Sep 24, 2024

Capital Change Notice

==> picture [90 x 45] intentionally omitted <==

Section 1: Issuer information
Name of issuer	Rua Bioscience Limited
NZX ticker code	RUA
Class of financial product	Ordinary Shares
ISIN (If unknown, check on NZX website)	NZRUAE0004S1
Currency	NZD
Section 2: Capital change details
Number issued/acquired/redeemed	3,968,254
Nominal value (if any)	NA
Issue/acquisition/redemption price per security	$0.0378
Nature of the payment (for example, cash or other consideration)	Cash comprising total proceeds of $150,000
Amount paid up (if not in full)	Fully paid
Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)1	2.48% of the total number of Ordinary Shares on issue.
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date)	NA
Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here)	Issue of ordinary shares under a placement announce on 20 September 2024 to fund short- term working capital requirements and authorised by a Board resolution on 19 September 2024.
Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption.	163, 718, 833
In the case of an acquisition of shares, whether those shares are to be held as treasury stock	NA
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made	Authorised by a resolution of the Board. The placement is made pursuant to NZX Listing Rule 4.5.1 and authorised by Board resolution dated 19 September 2024.

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements)	Issue of ordinary shares which rank equally with all other fully paid shares in Rua Bioscience Limited
Date of issue/acquisition/redemption2	23rdSeptember 2024
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Paul Naske
Contact person for this announcement	Paul Naske
Contact phone number	+64 21 445154
Contact email address	paul.naske@ruabio.com
Date of release through MAP	24thSeptember 2024

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).